Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems

Area of Science:

• Biochemistry and Molecular Biology
• Hepatology
• Metabolic Diseases

Background:

• Hepatic lipoprotein metabolism underpins major metabolic disorders like familial hypercholesterolemia, metabolic syndrome, and fatty liver disease.
• Dysregulation of lipoprotein uptake and secretion drives these conditions, posing significant health challenges.
• Current research models face limitations including interspecies differences, ethical constraints, and the use of non-physiological cell lines.

Purpose of the Study:

• To review current mechanistic concepts in lipoprotein metabolism, focusing on uptake and secretion.
• To provide a comprehensive overview and critique of experimental models used in lipoprotein research.
• To highlight the potential of advanced models, particularly 3D liver organoids, for future research.

Main Methods:

• Review of existing literature on human tracer studies, animal models, and 2D cell cultures.
• Analysis of limitations and physiological relevance of traditional experimental systems.
• Exploration of emerging models including precision-cut liver slices, liver-on-a-chip, and various 3D liver models (spheroids, organoids).

Main Results:

• Significant differences exist between human and animal lipoprotein metabolism, impacting model reliability.
• 2D cell cultures, often derived from cancerous cells, lack physiological relevance.
• 3D liver models, especially organoids derived from stem cells or liver tissue, offer improved physiological representation.

Conclusions:

• Advanced 3D liver models, particularly organoids, show great promise for studying lipoprotein metabolism and liver diseases.
• These models can overcome limitations of traditional systems, enabling more accurate mechanistic insights.
• Future research directions point towards the application of these advanced models in precision medicine for liver diseases.